Also found in: Medical.
AIPRIAngiotensin-converting-enzyme Inhibition in Progressive Renal Insufficiency
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
However those with moderate renal insufficiency showed 46% reduction in the same risk as shown in the ACE Inhibition in progressive renal insufficiency (AIPRI) study13.
A number of clinical studies on the role of ACE inhibitors in decelerating the progression of renal disease have been published, and among the first were those conducted by the Melbourne Diabetic Nephropathy Study Group, the ACE Inhibition in Progressive Renal Insufficiency (AIPRI) Study Group, and the North American Microalbuminuria Group.